Parkinson's disease dementia
Arq. NeuroPsiquiatr. vol.67 número4
... Parkinson’s disease dementia: recommendations from the Movement Disorder Society Task Force” which are, re- spectively: for attention, the serial 7s of the Mini-mental State Examination (MMSE); executive ...
2
Dementia in Parkinson's disease: a Brazilian sample
... of dementia associated with Parkinson’s disease (PD-D) in a Brazilian sample adopting clinical and diagnostic procedures recommended by the Movement Disorders Society ...Parkinson’s disease, ...
6
Intra-Rater, Inter-Rater and Test-Retest Reliability of an Instrumented Timed Up and Go (iTUG) Test in Patients with Parkinson's Disease.
... Measurements were conducted at the outpatient clinic and ward of the Department of Neuro- degenerative Diseases of the Center for Neurology of the University of Tübingen, the Gertrudis Klinik, Biskirchen, and a Physical ...
11
Fluency in Parkinson's disease: disease duration, cognitive status and age
... The general inclusion criteria for both groups were as fol- lows: age greater than or equal to 50 years; schooling greater than or equal to 4 years; absence of personal or familial his- tory of developmental or ...
7
Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy.
... Parkinson’s disease (PD) and dementia with Lewy bodies ...PD dementia (PDD) versus AD patients and non-demented ...mirror disease-specific neuropathological mechanisms but may also serve as ...
8
Imaging Striatal Microglial Activation in Patients with Parkinson's Disease.
... Translocator protein 18 kDa (TSPO) has been studied as a potential in vivo biomarker of reactive gliosis and inflammation associated with a variety of neuropathological conditions [6]. TSPO is located in the outer ...
10
Gene Expression Differences in Peripheral Blood of Parkinson ’s Disease Patients with Distinct Progression Profiles
... Parkinson’s Disease (PD) is a multi-system, disabling, insidiously progressive neurodegenera- tive condition affecting 1–2% of the population over the age of 60 ...of disease progression and to achieve a ...
19
Dement. neuropsychol. vol.2 número2
... frontotemporal dementia (FTD), Alzheimer’s disease (AD), Huntington’s disease (HD) and Parkinson’s disease (PD), but it is ...frontotemporal dementia (bv-FTD) (64), AD (96), PD (215) ...
6
Arq. NeuroPsiquiatr. vol.70 número8
... Parkinson’s Disease Rating Scale (UPDRS) Part I, Cornell Scale for the Assessment of Depression in Dementia (CSDD) and the Center for Epidemiologic Studies Depression Scale ...
4
Depression increases in patients with Parkinson?s disease according to the increasing severity of the cognitive impairment
... 10/66 Dementia Research Group’s research has been funded by the Wellcome Trust Health Consequences of Population Change Programme (GR066133 – Prevalence phase in Cuba and Brazil; GR08002- Incidence phase in Peru, ...
4
Dement. neuropsychol. vol.7 número1
... Figure 1. [A and B] Typical frontotemporal atrophy in a case of Pick’s disease. [C] Pick bodies in dentate neurons of the hippocampus (Tau immunochemistry). [D] Astrocytic plaque in a CBD case (frontal cortex, Tau ...
8
Dement. neuropsychol. vol.7 número4
... Clinical Dementia Rating (CDR), foram elaboradas para graduar a doença de Alzheimer (DA) e não incluem os sintomas específicos da degeneração lobar frontotemporal ...Frontotemporal Dementia Rating Scale ...
10
Sixty hertz neurostimulation amplifies subthalamic neural synchrony in Parkinson's disease.
... This is the first study to investigate the effects of 60 Hz DBS on neural synchrony in the STN in people with Parkinson’s disease. Intra-operative 60 Hz DBS amplified baseline neural synchro- ny in contrast to the ...
12
Trends Psychiatry Psychother. vol.38 número1
... Results: People with YOD rated their own QoL signiicantly hi- gher than their caregivers. Greater awareness of disease among people with YOD is associated with better QoL in caregivers. A relationship was found ...
8
Radiol Bras vol.50 número4
... Parkinson’s disease and atypical ...son’s disease has expanded, as has its role in the differ- ential diagnosis between Parkinson’s disease and atypical parkinsonism (7–9) ...
8
Remembering the forgotten non-communicable diseases
... ney disease. Peter Burney reminds us that the disease burden from asthma is not declining very much at all, and that health services, particularly in poor countries, are ill-equipped to manage the case ...
19
Rev. Bras. Psiquiatr. vol.38 número3
... Our study has limitations that should be addressed. First, its cross-sectional design limits its potential to set predictive models of functional loss. In a longitudinal perspective, we could test whether patients with ...
4
Dement. neuropsychol. vol.1 número2
... by the emergence of psychosis. In the context of schizo- phrenia and allied disorders, “psychosis” refers to a syn- drome characterized by hallucinations (most commonly auditory) and delusions (most often persecutory), ...
7
Arq. NeuroPsiquiatr. vol.73 número5
... he study of social cognition runs parallel to the study of traditional cognitive tasks in the ield of dementia. It is possible that the diferent performance on tests that evaluate social cog- nition may be of ...
2
Caregiver awareness of cerebrovascular risk of patients with dementia due to Alzheimer's disease in São Paulo, Brazil
... in dementia due to Alzheimer’s disease ...Clinical Dementia Rating scores, cerebrovascular risk, pharmacotherapy, dietary therapy and practice of physical ...
5